Skip to main content
. 2016 Mar 28;90(8):4017–4031. doi: 10.1128/JVI.02898-15

FIG 3.

FIG 3

Characterization of recombinant gp120s for ELISA binding with CD4-Ig (top) and VRC01 (middle) and for neutralization competition with VRC01 (bottom). The gp120 sequences were based on JR-FL, Yu2, and AC10.29, as indicated. Each strain was tested as the WT or with a point mutation (D368R or W479A). (Bottom) For neutralization competition assays, the D368R and W479A gp120 mutants were tested at 25 μg/ml to adsorb VRC01 neutralizing activity against the indicated gp120-matched strains.